2024 forecast: As CDMOs come off pandemic's highs and lows, employment and funding hitches persist
2024 forecast: As CDMOs come off pandemic's highs and lows, employment and funding hitches persist fkansteiner Thu, 01/04/2024 - 14:23
2024 forecast: As CDMOs come off pandemic's highs and lows, employment and funding hitches persist fkansteiner Thu, 01/04/2024 - 14:23
CVS Caremark to kick AbbVie's Humira off some formularies in favor of cheaper biosimilars zbecker Thu, 01/04/2024 - 11:09
Bluebird bio's Lyfgenia launch progresses with 2nd major outcomes-based coverage deal aliu Thu, 01/04/2024 - 11:08
Novo Nordisk, Eli Lilly's weight-loss drugs under FDA scrutiny for suicidal thoughts, hair loss kdunleavy Thu, 01/04/2024 - 10:47
Leading a New Era of Patient-Inspired Neuroscience jpiatt Thu, 01/04/2024 - 10:40
Bain Capital eyes potential €1B sale of Dutch antibiotics manufacturer Centrient: report fkansteiner Thu, 01/04/2024 - 09:21
AGC extends CDMO expansion spree, plans second manufacturing facility in Japan kdunleavy Thu, 01/04/2024 - 07:40
Pfizer rings in New Year with hemophilia B gene therapy nod in Canada esagonowsky Wed, 01/03/2024 - 16:20